From: Screen or not to screen for peripheral arterial disease: guidance from a decision model
Model parameter | Value | Probability distribution | Moments of the probability distribution ά/min, β/max | Source |
---|---|---|---|---|
Discount rates | Â | Â | Â | Â |
Cost discount rate | 4% | Fixed | - | [14] |
Outcome discount rate | 1.5% | Fixed | - | [14] |
Costs (Euros)* | Â | Â | Â | Â |
Cost of ankle brachial index test | 74†| BETA Pert | 55.7;92.8 | MUMC‡ |
Annual cost of PAD treatment | 2369 | GAMMA | 325.09;7.29 | [18] |
Annual cost of Aspirin | 10 | Fixed | Â | [19] |
Annual cost of Clopidogrel | 19 | Fixed | Â | [19] |
Costs of Amputation | 14343†| BETA Pert | 10683;17804 | [20] |
Cost of AMI in first year | 25328 | GAMMA | 100;253.27 | [21] |
Annual costs of MI treatment in subsequent years | 3584 | GAMMA | 99.92;35.86 | [21] |
Cost of stroke in first year | 27964 | GAMMA | 99.99;279.66 | [21] |
Annual costs of treatment of stroke in subsequent years | 10646 | GAMMA | 99.99;106.47 | [21] |
Costs of bleeding | 3457 | GAMMA | 99.87;34.61 | [21] |
ABI test accuracy | Â | Â | Â | Â |
Sensitivity | 0.90†| BETA Pert | 0.68;1 | [22] |
Specificity | 0.95†| BETA Pert | 0.71;1 | [22] |
Incidence/prevalence of PAD | Â | Â | Â | Â |
Prevalence of PAD | 0.184 | BETA | 1372;6082 | [6] |
Annual incidence of PAD in 55–64 years aged | 0.005 | BETA | See Additional file 1 | [23] |
Annual incidence of PAD in 65–74 years aged | 0.007 | BETA | See Additional file 1 | [23] |
Annual incidence of PAD in 75–84 years aged | 0.008 | BETA | See Additional file 1 | [23] |
Annual incidence of PAD in >85 years aged | 0.010 | BETA | See Additional file 1 | [23] |
Event probabilities | Â | Â | Â | Â |
Probability of amputation in patients with no PAD | 0.003 | BETA | 32;11734 | [24] |
Probability of AMI in patients with no PAD | 0.008 | BETA | 89;11677 | [24] |
Probability of stroke in patients with no PAD | 0.008 | BETA | 94;11672 | [24] |
Probability of amputation in PAD patients | 0.016 | BETA | 140;8441 | [24] |
Probability of AMI in PAD patients | 0.013 | BETA | 111;8470 | [24] |
Probability of stroke in PAD patients | 0.019 | BETA | 165;8416 | [24] |
Probability of symptomatic PAD | 0.3 | BETA | 138;320 | [25] |
Relative risk in PAD patients on low dose aspirin | 0.78 | BETA | 25.45;7.2 | [26] |
Probability of bleeding in PAD patients on aspirin | 0.026 | BETA | 255;9311 | [27] |
Relative risk in PAD patients on Clopidogrel | 0.616 | BETA | See Additional file 1 | [28] |
Probability of bleeding in PAD patients on Clopidogrel | 0.020 | BETA | 191;9386 | [27] |
Mortality in ‘untreated’ patients |  |  |  |  |
Annual probability of death in PAD patients | 0.037 | BETA | 323;8258 | [24] |
Probability of death in post Amputation | 0.155 | BETA | 4297;21281 | [29] |
annual probability of death in post MI alive patients | 0.028 | BETA | 521;17492 | [24] |
annual probability of death in post stroke alive patients | 0.031 | BETA | 1212;37390 | [24] |
Utility | Â | Â | Â | Â |
PAD | 0.652 | BETA | 0.8;0.4 | [30] |
Amputation | 0.45 | BETA | 210.8;257.7 | [31] |
Post MI | 0.671 | BETA | 69.3;34 | [30] |
Post stroke | 0.519 | BETA | 2.7;2.5 | [30] |
Post bleed | 0.627 | BETA | 405.6;241.13 | [30] |